Estrogen Receptor and Progesterone Receptor As Predictive Biomarkers of Response to Endocrine Therapy: A Prospectively Powered Pathology Study in the Tamoxifen and Exemestane Adjuvant Multinational Trial

PURPOSE: The Tamoxifen and Exemestane Adjuvant Multinational (TEAM) trial included a prospectively planned pathology substudy testing the predictive value of progesterone receptor (PgR) expression for outcome of estrogen receptor–positive (ER-positive) early breast cancer treated with exemestane ver...

Полное описание

Сохранить в:
Библиографические подробности
Главные авторы: Bartlett, John M.S., Brookes, Cassandra L., Robson, Tammy, van de Velde, Cornelis J.H., Billingham, Lucinda J., Campbell, Fiona M., Grant, Margaret, Hasenburg, Annette, Hille, Elysée T.M., Kay, Charlene, Kieback, Dirk G., Putter, Hein, Markopoulos, Christos, Kranenbarg, Elma Meershoek-Klein, Mallon, Elizabeth A., Dirix, Luc, Seynaeve, Caroline, Rea, Daniel
Формат: Artigo
Язык:Inglês
Опубликовано: American Society of Clinical Oncology 2011
Предметы:
Original Reports
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC3082973/
https://ncbi.nlm.nih.gov/pubmed/21422407
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2010.30.3677
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы